v3.25.1
Condensed Consolidated Balance Sheets (unaudited) - USD ($)
$ in Millions
Mar. 31, 2025
Dec. 31, 2024
Current Assets:    
Cash and cash equivalents $ 1,384.5 $ 525.5
Accounts receivable, less allowance for credit losses 1,533.4 1,480.7
Inventories 2,244.2 2,235.3
Prepaid expenses and other current assets 428.2 430.1
Total Current Assets 5,590.2 4,671.5
Property, plant and equipment, net 2,064.9 2,048.8
Goodwill 8,988.6 8,951.1
Intangible assets, net 4,468.0 4,598.4
Other assets 1,072.1 1,095.5
Total Assets 22,183.9 21,365.3
Current Liabilities:    
Accounts payable 301.3 194.6
Other current liabilities 1,393.7 1,393.3
Current portion of long-term debt 600.0 863.0
Total Current Liabilities 2,294.9 2,450.9
Other long-term liabilities 908.9 1,096.6
Long-term debt 6,576.3 5,341.6
Total Liabilities 9,780.0 8,889.1
Commitments and Contingencies (Note 15)
Stockholders' Equity:    
Common stock, $0.01 par value, one billion shares authorized, 318.4 million shares as of March 31, 2025 (317.5 million as of December 31, 2024) issued 3.2 3.2
Paid-in capital 10,086.6 10,038.1
Retained earnings 11,229.7 11,095.3
Accumulated other comprehensive loss (287.3) (262.8)
Treasury stock, 120.5 million shares as of March 31, 2025 (118.4 million as of December 31, 2024) (8,637.1) (8,405.7)
Total Zimmer Biomet Holdings, Inc. stockholders' equity 12,395.1 12,468.1
Noncontrolling interest 8.7 8.1
Total Stockholders' Equity 12,403.8 12,476.2
Total Liabilities and Stockholders' Equity $ 22,183.9 $ 21,365.3